78 related articles for article (PubMed ID: 15239124)
1. Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs.
Liang Y; O'Driscoll L; McDonnell S; Doolan P; Oglesby I; Duffy K; O'Connor R; Clynes M
Int J Cancer; 2004 Sep; 111(4):484-93. PubMed ID: 15239124
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro.
O'Driscoll L; Linehan R; Liang YH; Joyce H; Oglesby I; Clynes M
Anticancer Res; 2002; 22(6A):3117-25. PubMed ID: 12530054
[TBL] [Abstract][Full Text] [Related]
3. Proteomic investigation of taxol and taxotere resistance and invasiveness in a squamous lung carcinoma cell line.
Murphy L; Henry M; Meleady P; Clynes M; Keenan J
Biochim Biophys Acta; 2008 Sep; 1784(9):1184-91. PubMed ID: 18503785
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs).
Duffy CP; Elliott CJ; O'Connor RA; Heenan MM; Coyle S; Cleary IM; Kavanagh K; Verhaegen S; O'Loughlin CM; NicAmhlaoibh R; Clynes M
Eur J Cancer; 1998 Jul; 34(8):1250-9. PubMed ID: 9849488
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNA.
NicAmhlaoibh R; Heenan M; Cleary I; Touhey S; O'Loughlin C; Daly C; Nuñez G; Scanlon KJ; Clynes M
Int J Cancer; 1999 Jul; 82(3):368-76. PubMed ID: 10399954
[TBL] [Abstract][Full Text] [Related]
6. Development of taxane resistance in a panel of human lung cancer cell lines.
Breen L; Murphy L; Keenan J; Clynes M
Toxicol In Vitro; 2008 Aug; 22(5):1234-41. PubMed ID: 18514476
[TBL] [Abstract][Full Text] [Related]
7. Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A.
Clynes M; Redmond A; Moran E; Gilvarry U
Cytotechnology; 1992; 10(1):75-89. PubMed ID: 1369413
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
10. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell line.
Keenan J; Murphy L; Henry M; Meleady P; Clynes M
Proteomics; 2009 Mar; 9(6):1556-66. PubMed ID: 19242932
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection.
Andoh T; Nishizawa M; Hida T; Ariyoshi Y; Takahashi T; Ueda R
Oncol Res; 1996; 8(6):229-38. PubMed ID: 8895198
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis to dissect mitoxantrone resistance-associated proteins in a squamous lung carcinoma.
Murphy L; Clynes M; Keenan J
Anticancer Res; 2007; 27(3A):1277-84. PubMed ID: 17593620
[TBL] [Abstract][Full Text] [Related]
15. Absence of correlation between chemo- and radioresistance in a range of human tumour cell lines.
Heenan M; Kavanagh K; Redmond A; Maher M; Dolan E; O'Neill P; Moriarty M; Clynes M
Cytotechnology; 1996; 19(3):237-42. PubMed ID: 8862012
[TBL] [Abstract][Full Text] [Related]
16. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
Cleary I; Doherty G; Moran E; Clynes M
Biochem Pharmacol; 1997 May; 53(10):1493-502. PubMed ID: 9260877
[TBL] [Abstract][Full Text] [Related]
17. Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro.
Rigalli JP; Reuter T; Herold-Mende C; Dyckhoff G; Haefeli WE; Weiss J; Theile D
Cancer Chemother Pharmacol; 2013 May; 71(5):1335-43. PubMed ID: 23479137
[TBL] [Abstract][Full Text] [Related]
18. [Expression of multidrug resistance-associated protein gene in non-small cell lung cancer].
Xu M; Li J; Xia Q
Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):268-70. PubMed ID: 11775850
[TBL] [Abstract][Full Text] [Related]
19. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma.
Shikada Y; Yoshino I; Okamoto T; Fukuyama S; Kameyama T; Maehara Y
Clin Cancer Res; 2003 Nov; 9(14):5282-6. PubMed ID: 14614010
[TBL] [Abstract][Full Text] [Related]
20. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R
Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
